Lisa G. Wolf
President, CFO & COOMs. Lisa G. Wolf is the President since September 1, 2026, Chief Financial Officer since July 07, 2025 and Chief Operating Officer since August 16, 2026 at Valion Bio, Inc. Previously, Ms. Wolf served as Principal Financial & Principal Accounting Officer from October 1, 2024 to August 16, 2026 and Interim Chief Financial Officer until July 07, 2025 at Valion Bio, Inc. (formerly known as Tivic Health Systems, Inc.). Ms. Wolf served as Vice President of Murdock Martell, Chief Accounting Officer from May 2021 to 2022, Vice President of Finance from 2016 to 2019 and Controller from June 2014 to 2016 at Resonant Inc. Ms. Wolf served as Controller of ArmaGen Inc., held several positions as Controller at a variety of both public and private companies and held positions at Arthur Andersen. Ms. Wolf holds a BS in Business Administration with an emphasis in Accounting from California State University, Northridge and is a CPA.
Positions
- Company NameValion Bio, Inc.Stock CodeVBIOPositionPresident, CFO & COO
